Stage IIIB Breast Cancer Completed Phase 1 / 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs